Reply on Imaging with Caelyx in Brain Tumours
Author Information
Author(s): Koukourakis M I
Primary Institution: Democritus University of Thrace
Hypothesis
Does the simple labelling technique effectively label Caelyx for imaging in glioblastomas and metastatic brain tumours?
Conclusion
The imaging quality of 99mTc-DTPA-Caelyx is superior to that of 99mTc-DTPA alone in certain cancer patients.
Supporting Evidence
- Imaging with 99mTc-DTPA was of unacceptably poor quality in some cases.
- Liposomal imaging was superior to sestamibi in more than 10 glioma patients.
- The study suggests that 99mTc-DTPA may label liposomes without internalization.
Takeaway
This study shows that a special way of tagging a cancer drug helps doctors see tumors better in some patients.
Methodology
The study compared imaging results from 30 lung cancer patients using different radio-pharmaceuticals.
Limitations
The study's findings are based on a limited number of patients and may not be generalizable.
Participant Demographics
Patients included were primarily those with non-small cell lung cancer and head and neck cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website